FDA NDC
AdreView
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 17156-235
- Proprietary name
- AdreView
- Nonproprietary name
- Iobenguane I-123
- Labeler
- Medi-Physics Inc.
- Dosage form
- INJECTION
- Strength
- 2 mCi/mL
Run it in Rivvi
Which 2027 plans near you dropped or restricted Iobenguane I-123?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.